Patent · US Active

Salt hydrates

US8329919B2 · kind B2 · utility

0Cited by

3References

1Claims

0Family size

Assignee

Novartis AG · CH

Inventor

Erwin Marti · Basel, CH

Key dates

Filing date	Sep 28, 2011
Grant date	Dec 11, 2012
Priority date	—
Expiry date	Sep 28, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to new forms of salts of valsartan or crystalline, also partly crystalline and amorphous salts of valsartan, the respective production and usage, and pharmaceutical preparations containing such a salt.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.